Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Kaiser Permanente Ventures (KPV) was established over 25 years ago and is headquartered in the United States. This venture capital firm operates as a strategic investing program that focuses on healthcare innovation. KPV collaborates with Kaiser Permanente and external partners to invest in healthcare companies that address significant needs within the healthcare system. The firm has developed a strong reputation for its commitment to enhancing healthcare delivery through targeted investments.
Currently, KPV manages a diverse portfolio of over 67 companies, showcasing its active role in the healthcare sector. The firm primarily invests in the United States and has built a robust network of partnerships that enhance its investment capabilities. KPV's notable milestones include its consistent focus on healthcare innovation and its ability to identify and support companies that provide clear value to patients and providers.
Kaiser Permanente Ventures invests across various sectors within healthcare, including Health Information Technology, Digital Health, Healthcare Services, Medical Devices, and Diagnostics and Precision Medicine. The firm targets innovations that deliver clear value to patients, providers, and healthcare delivery systems. KPV's investment strategy encompasses multiple stages, including Seed, Series A, Series B, and Growth Equity, allowing for flexibility in supporting companies at different phases of their development.
The firm seeks to partner with startups that demonstrate a strong potential for addressing significant healthcare needs. KPV looks for founders who are committed to creating impactful solutions and who possess a deep understanding of their respective markets. The organization emphasizes the importance of strategic partnerships and co-investment opportunities, which enhance the overall value proposition for portfolio companies.
Kaiser Permanente Ventures has invested in a diverse array of over 67 companies, with a focus on healthcare innovation. Notable portfolio companies include:
This portfolio reflects KPV's commitment to investing in companies that address critical challenges within the healthcare system, showcasing a range of innovative solutions that enhance patient care and healthcare delivery.
Amy Belt Raimundo: Vice President & Managing Director with extensive experience in healthcare investments and strategic partnerships.
Brian Wojtowicz: Executive Director, known for leading significant investments in healthcare innovation.
Daniel van den Bergh: Senior Investment Director with a strong background in healthcare technology and investment strategy.
Gina Crisosto: Chief of Staff, facilitating operations and strategic initiatives within the firm.
Jin Zhang: Principal, focusing on identifying and evaluating investment opportunities in healthcare.
Alexandra Shandiz: Principal with expertise in healthcare services and technology investments.
Samuel Jazzo: Senior Associate involved in due diligence and portfolio management.
Jess Miao: Portfolio Analyst supporting investment analysis and reporting.
Chris Grant: Co-Founder & Chief Operating Officer and Executive Vice President of The Permanente Federation LLC, bringing extensive operational experience to the firm.
To pitch to Kaiser Permanente Ventures, startups should visit their website at kpventures.com for detailed instructions. The firm prefers a clear and concise pitch deck that outlines the business model, market opportunity, and the innovation's impact on healthcare. Startups should expect a response within a few weeks after submission, and warm introductions are encouraged to enhance the likelihood of engagement.
In recent months, Kaiser Permanente Ventures has continued to expand its portfolio, investing in innovative healthcare companies that address pressing needs. Notable investments include:
These investments reflect KPV's ongoing commitment to supporting healthcare innovation and improving patient outcomes.
What are Kaiser Permanente Ventures' investment criteria?
Kaiser Permanente Ventures focuses on healthcare innovations that provide clear value to patients, providers, and healthcare delivery systems. The firm invests in various sectors, including digital health, medical devices, and diagnostics, targeting companies at Seed, Series A, Series B, and Growth Equity stages.
How can startups apply or pitch to Kaiser Permanente Ventures?
Startups interested in pitching to Kaiser Permanente Ventures can visit their website at kpventures.com for more information on the application process. The firm encourages potential partners to present innovative solutions that address significant healthcare needs.
What makes Kaiser Permanente Ventures different from other investors?
Kaiser Permanente Ventures distinguishes itself through its strategic partnerships with Kaiser Permanente and its focus on healthcare innovation. The firm leverages its extensive network and resources to support portfolio companies effectively.
What is the geographic scope of Kaiser Permanente Ventures?
The firm primarily invests in companies based in the United States, focusing on innovations that can significantly impact the U.S. healthcare system.
What is Kaiser Permanente Ventures' approach to post-investment involvement?
Kaiser Permanente Ventures actively engages with its portfolio companies, providing operational support, strategic guidance, and access to a network of healthcare professionals and resources to help them succeed.
What is the typical check size for investments made by Kaiser Permanente Ventures?
While specific check sizes are not disclosed, Kaiser Permanente Ventures invests across various stages, indicating a flexible approach to funding that aligns with the needs of its portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.